Evidence map›Paper›PMID 36561708›Full record

ReviewOne health (Amsterdam, Netherlands)2022

One Health collaboration with and among EU Agencies - Bridging research and policy.

Stef Bronzwaer, Mike Catchpole, Wim de Coen, Zoe Dingwall, Karen Fabbri, Clémence Foltz, Catherine Ganzleben, Robert van Gorcom, Anthony Humphreys, Pikka Jokelainen and 3 more

Abstract readReview
In one paragraph

Review in One health (Amsterdam, Netherlands), 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed.

  1. Article
  2. Review
  3. Review
  4. Scientific cooperation among Europe's One Health agencies.One health (Amsterdam, Netherlands) · 2025
    Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Review
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Stef BronzwaerEuropean Food Safety Authority (EFSA), Via Carlo Magno 1A, 43126 Parma, Italy.
Mike CatchpoleEuropean Centre for Disease Prevention and Control (ECDC), 171 83 Stockholm, Sweden.
Wim de CoenEuropean Chemicals Agency (ECHA), Telakkakatu 6, 00150 Helsinki, Finland.
Zoe DingwallEuropean Parliament, Rue Wiertzstraat, B-1047 Brussels, Belgium.
Karen FabbriEuropean Commission (DG RTD), 1049 Brussels, Belgium.
Clémence FoltzEuropean Food Safety Authority (EFSA), Via Carlo Magno 1A, 43126 Parma, Italy.
Catherine GanzlebenEuropean Environment Agency (EEA), Kongens Nytorv 6, 1050 Copenhagen, Denmark.
Robert van GorcomWageningen Food Safety Research, Akkermaalsbos 2, 6708 WB Wageningen, the Netherlands.
Anthony HumphreysEuropean Medicines Agency, Domenico Scarlattilaan 6, 1083 HS Amsterdam, the Netherlands.
Pikka JokelainenStatens Serum Institut, Artillerivej 5, 2300 Copenhagen, Denmark.
Ernesto LiebanaEuropean Food Safety Authority (EFSA), Via Carlo Magno 1A, 43126 Parma, Italy.
Valentina RizziEuropean Food Safety Authority (EFSA), Via Carlo Magno 1A, 43126 Parma, Italy.
Bernhard UrlEuropean Food Safety Authority (EFSA), Via Carlo Magno 1A, 43126 Parma, Italy.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

In the coming decade, Europe will dedicate billions of euros to the necessary research and innovation (R&I) to support a transition to safe and sustainable food systems. EU Agencies, individually and even more so collectively, can make a difference in supporting the European research agenda. EU Agencies are knowledge centres, bringing together know-how to inform policy makers. EU Agencies that have traditionally dealt with aspects of human health, animal health, plant health and ecosystem health in silos, now need to take a broader perspective and move towards a One Health (OH) approach. In this paper, the authors highlight the need for more transdisciplinary cooperation in support of the One Health approach, identify challenges in strengthening interagency cooperation and provide recommendations to address them. EU Agencies are natural bridges between the scientific community and policy-makers and need to dedicate time and effort in fostering this dialogue, e.g. by engaging with relevant initiatives, research projects and European Partnerships. Research generates evidence that can be used also for regulatory science, in support of policy-making. It is urgent to define transdisciplinary research needs and formulate a One Health research agenda. This would be facilitated by establishing transdisciplinary One Health Research & Innovation governance, both at national and EU levels. Ongoing large initiatives, such as the One Health European Joint Programme, have demonstrated that active dialogue with national ministries and EU agencies is beneficial for all parties. Involvement of EU Agencies in the programming of the EU Research Framework programmes is beneficial, because of their regulatory science perspective, their expertise and current or future tasks on research topics. It is timely for EU Agencies to demonstrate leadership in moving the One Health agenda forward and it is encouraging that EU Agencies have committed to establish a cross-agency task force on One Health.

Indexed as

CooperationEuropeFood safetyOne healthResearchRisk assessmentScience-policy-interface

Identifiers

PMID36561708
PMCPMC9767809

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.